Angiotensin-converting enzyme gene insertion/deletion polymorphism in Kuwaiti children with retinopathy of prematurity

被引:20
作者
Haider, MZ
Devarajan, LV
Al-Essa, M
Kumar, H
机构
[1] Kuwait Univ, Fac Med, Dept Paediat, Safat 13110, Kuwait
[2] Ibn Sina Hosp, Ophthalmol Dept, Safat, Kuwait
来源
BIOLOGY OF THE NEONATE | 2002年 / 82卷 / 02期
关键词
angiotensin-converting enzyme; genotype; polymerase chain reaction; polymorphism; retinopathy of prematurity;
D O I
10.1159/000063092
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Retinopathy of prematurity (ROP) is a disease characterized by neovascularization which occurs in infants with short gestational age and low birth weight and can lead to retinal detachment and blindness. In a proportion of ROP cases, the disease progresses to advanced stages despite rigorous intervention. The genotypes for angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism were determined in 181 premature Kuwaiti infants using a polymerase chain reaction (PCR) method. The incidence of different I/D genotypes was compared in ROP cases (n = 74) and non-ROP controls (n = 107) and within 2 subgroups of ROP patients: (1) in which ROP regressed spontaneously (stages 1-3, n = 53), and (2) in which ROP progressed to advanced stages (stages 4 and 5, n = 21). When the ROP cases were considered collectively as one group, the incidence of the DID genotype was almost identical to that of non-ROP controls. The incidence of heterozygous ID genotype was higher in non-ROP controls. The incidence of the II genotype was higher in ROP cases compared to non-ROP controls (p < 0.01). In contrast to this, when ROP cases were divided in 2 subgroups the incidence of the DID genotype was significantly higher in advanced stage ROP cases compared to spontaneously regressing ROP cases (p < 0.04). The incidences of ID and II genotypes were not significantly different amongst the 2 subgroups of ROP patients. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:84 / 88
页数:5
相关论文
共 35 条
[1]   Angiotensin-converting enzyme gene insertion/deletion polymorphism and renal damage in childhood uropathies [J].
Al-Eisa, A ;
Haider, MZ ;
Srivastva, BS .
PEDIATRICS INTERNATIONAL, 2000, 42 (04) :348-353
[2]   Rate of and risk factors associated with retinopathy of prematurity: A prospective study from Kuwait [J].
Al-Essa, M ;
Azad, RV ;
Rashwan, N .
MEDICAL PRINCIPLES AND PRACTICE, 1999, 8 (02) :115-118
[3]  
ARNOLD RW, 1994, J PEDIATR OPHTHALMOL, V31, P192
[4]   ISOLATION OF A CANDIDATE GENE FOR NORRIE DISEASE BY POSITIONAL CLONING [J].
BERGER, W ;
MEINDL, A ;
VANDEPOL, TJR ;
CREMERS, FPM ;
ROPERS, HH ;
DOERNER, C ;
MONACO, A ;
BERGEN, AAB ;
LEBO, R ;
WARBURG, M ;
ZERGOLLERN, L ;
LORENZ, B ;
GAL, A ;
BLEEKERWAGEMAKERS, EM ;
MEITINGER, T .
NATURE GENETICS, 1992, 1 (03) :199-203
[5]  
Berger W, 1998, ACTA ANAT, V162, P95
[6]   RETINOPATHY OF PREMATURITY [J].
BOSSI, E ;
KOERNER, F .
INTENSIVE CARE MEDICINE, 1995, 21 (03) :241-246
[7]   Role of the renin-angiotensin system in disorders of the urinary tract [J].
Brock, JW ;
Hunley, TE ;
Adams, MC ;
Kon, V .
JOURNAL OF UROLOGY, 1998, 160 (05) :1812-1819
[8]   DELETION POLYMORPHISM IN THE GENE FOR ANGIOTENSIN-CONVERTING ENZYME IS A POTENT RISK FACTOR FOR MYOCARDIAL-INFARCTION [J].
CAMBIEN, F ;
POIRIER, O ;
LECERF, L ;
EVANS, A ;
CAMBOU, JP ;
ARVEILER, D ;
LUC, G ;
BARD, JM ;
BARA, L ;
RICARD, S ;
TIRET, L ;
AMOUYEL, P ;
ALHENCGELAS, F ;
SOUBRIER, F .
NATURE, 1992, 359 (6396) :641-644
[9]   Angiotensin-converting enzyme insertion deletion polymorphism and cerebrovascular disease [J].
Catto, A ;
Carter, AM ;
Barrett, JH ;
Stickland, M ;
Bamford, J ;
Davies, JA ;
Grant, PJ .
STROKE, 1996, 27 (03) :435-440
[10]   ISOLATION AND CHARACTERIZATION OF A CANDIDATE GENE FOR NORRIE DISEASE [J].
CHEN, ZY ;
HENDRIKS, RW ;
JOBLING, MA ;
POWELL, JF ;
BREAKEFIELD, XO ;
SIMS, KB ;
CRAIG, IW .
NATURE GENETICS, 1992, 1 (03) :204-208